3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase 2
2
Phase 1
1
Status
Completed
2
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Endocrine
1
Conditions
Hypertension
2
Diabetes Mellitus, Type 2
2
Cushing Syndrome
2
ACTH Syndrome, Ectopic
2
Pituitary ACTH Hypersecretion
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Fallopian Tube Neoplasms
1
Interventions
relacorilant
2
sacubitril and valsartan sodium hydrate drug combination
1
aliskiren
1
Enalapril
1
Amlodipine, Valsartan Drug Combination
1
Amlodipine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Hypertension
×
relacorilant
×
Clear all
NCT04308590
2025-09-04
GRADIENT
Corcept Therapeutics
Phase 3
Completed
137 enrolled
25 charts
NCT03697109
2025-07-16
GRACE
Corcept Therapeutics
Phase 3
Completed
152 enrolled
28 charts